Choosing the right cell line for breast cancer research.

  • Holliday D
  • Speirs V
  • 1.2k

    Readers

    Mendeley users who have this article in their library.
  • N/A

    Citations

    Citations of this article.

Abstract

Breast cancer is a complex and heterogeneous disease. Gene expression profiling has contributed significantly to our understanding of this heterogeneity at a molecular level, refining taxonomy based on simple measures such as histological type, tumour grade, lymph node status and the presence of predictive markers like oestrogen receptor and human epidermal growth factor receptor 2 (HER2) to a more sophisticated classification comprising luminal A, luminal B, basal-like, HER2-positive and normal subgroups. In the laboratory, breast cancer is often modelled using established cell lines. In the present review we discuss some of the issues surrounding the use of breast cancer cell lines as experimental models, in light of these revised clinical classifications, and put forward suggestions for improving their use in translational breast cancer research.

Author-supplied keywords

  • Animals
  • Breast Neoplasms
  • Breast Neoplasms: metabolism
  • Breast Neoplasms: pathology
  • Cell Line, Tumor
  • Estrogen Receptor alpha
  • Estrogen Receptor alpha: metabolism
  • Female
  • Humans
  • Mice
  • Neoplastic Stem Cells
  • Neoplastic Stem Cells: pathology
  • Receptor, erbB-2
  • Receptor, erbB-2: metabolism
  • Receptors, Progesterone
  • Receptors, Progesterone: metabolism
  • Research Design
  • Xenograft Model Antitumor Assays

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Get full text

Authors

  • Deborah L Holliday

  • Valerie Speirs

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free